Literature DB >> 11160124

Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP).

N Balaban1, T Goldkorn, Y Gov, M Hirshberg, N Koyfman, H R Matthews, R T Nhan, B Singh, O Uziel.   

Abstract

Staphylococcus aureus can cause disease through the production of toxins. Toxin production is autoinduced by the protein RNAIII-activating protein (RAP) and by the autoinducing peptide (AIP), and is inhibited by RNAIII-inhibiting peptide (RIP) and by inhibitory AIPs. RAP has been shown to be a useful vaccine target site, and RIP and inhibitory AIPs as therapeutic molecules to prevent and suppress S. aureus infections. Development of therapeutic strategies based on these molecules has been hindered by a lack of knowledge of the molecular mechanisms by which they activate or inhibit virulence. Here, we show that RAP specifically induces the phosphorylation of a novel 21-kDa protein, whereas RIP inhibits its phosphorylation. This protein was termed target of RAP (TRAP). The synthesis of the virulence regulatory molecule, RNAIII, is not activated by RAP in the trap mutant strain, suggesting that RAP activates RNAIII synthesis via TRAP. Phosphoamino acid analysis shows that TRAP is histidine-phosphorylated, suggesting that TRAP may be a sensor of RAP. AIPs up-regulate the synthesis of RNAIII also in trap mutant strains, suggesting that TRAP and AIPs activate RNAIII synthesis via distinct signal transduction pathways. Furthermore, TRAP phosphorylation is down-regulated in the presence of AIP, suggesting that a network of signal transduction pathways regulate S. aureus pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160124     DOI: 10.1074/jbc.m005446200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.

Authors:  P M Dunman; E Murphy; S Haney; D Palacios; G Tucker-Kellogg; S Wu; E L Brown; R J Zagursky; D Shlaes; S J Projan
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

2.  Structure of the signal transduction protein TRAP (target of RNAIII-activating protein).

Authors:  Kim Henrick; Miriam Hirshberg
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-06-22

Review 3.  Role of quorum sensing in bacterial infections.

Authors:  Israel Castillo-Juárez; Toshinari Maeda; Edna Ayerim Mandujano-Tinoco; María Tomás; Berenice Pérez-Eretza; Silvia Julieta García-Contreras; Thomas K Wood; Rodolfo García-Contreras
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

4.  RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.

Authors:  Paloma Anguita-Alonso; Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Vittorio Saba; Giorgio Scalise; Milica Sevo; Marina Tuzova; Robin Patel; Naomi Balaban
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

5.  Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence.

Authors:  Moshe Korem; Yael Gov; Madanahally D Kiran; Naomi Balaban
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 6.  Engineering approaches for the detection and control of orthopaedic biofilm infections.

Authors:  Garth D Ehrlich; Paul Stoodley; Sandeep Kathju; Yongjun Zhao; Bruce R McLeod; Naomi Balaban; Fen Ze Hu; Nicholas G Sotereanos; J William Costerton; Philip S Stewart; J Christopher Post; Qiao Lin
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

7.  Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.

Authors:  Naomi Balaban; Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Joel B Braunstein; Carmela Silvestri; Federico Mocchegiani; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

8.  Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation.

Authors:  Laura H Tsang; Sonja T Daily; Elizabeth C Weiss; Mark S Smeltzer
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

9.  A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan.

Authors:  Rajan P Adhikari; Staffan Arvidson; Richard P Novick
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

10.  RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.

Authors:  Oscar Cirioni; Roberto Ghiselli; Daniele Minardi; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Giovanni Muzzonigro; Vittorio Saba; Giorgio Scalise; Naomi Balaban; Andrea Giacometti
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.